Menu

Blog

Dec 13, 2024

Chroma Medicine, Nvelop Therapeutics Merge as nChroma Bio with Focus on Epigenetic Therapies

Posted by in categories: biotech/medical, genetics

The new company has also raised $75 million that will support the development of epigenetic editing therapies for hepatitis B and other disorders.

Leave a reply